Skip to main content
VCbacked
Log inGet Started

Rubi Laboratories

San Francisco, United States

Rubi Laboratories develops biocatalyst solutions that turn carbon emissions into carbon-negative textiles.

$7.5M raised
Mar 2026
Series Unknown
BiotechnologyCleanTechManufacturingSustainabilityTextiles

Top Investors

FH OnePlug and PlayNational Science FoundationCollaborative FundTalis Capital

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Rubi Laboratories

How much funding has Rubi Laboratories raised?
Rubi Laboratories has raised $7.5M in total funding. The most recent round was Series Unknown. The last funding was announced in March 2026.
Who are Rubi Laboratories's investors?
Rubi Laboratories's investors include FH One, Plug and Play, National Science Foundation, Collaborative Fund, Talis Capital.
Where is Rubi Laboratories headquartered?
Rubi Laboratories is headquartered in San Francisco, United States.
What does Rubi Laboratories do?
Rubi Laboratories develops biocatalyst solutions that turn carbon emissions into carbon-negative textiles.
What stage is Rubi Laboratories at?
Rubi Laboratories is at the Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Rubi Laboratories — Funding & Investors." VCBacked, March 17, 2026, https://www.vcbacked.co/company/rubi-laboratories. Accessed June 3, 2026.
APA
VCBacked. (2026). Rubi Laboratories — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/rubi-laboratories
Wikipedia (cite web)
{{cite web |title=Rubi Laboratories — Funding & Investors |url=https://www.vcbacked.co/company/rubi-laboratories |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong